Therapeutic exploitation of the p53 pathway
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (4), S38-S42
- https://doi.org/10.1016/s1471-4914(02)02309-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor proteinJournal of Molecular Biology, 2001
- Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studiesSeminars in Oncology, 2001
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- Activation of p53 by roscovitine-mediated suppression of MDM2 expressionOncogene, 2001
- Targeting gene expression to tumor cells with loss of wild-type p53 functionCancer Gene Therapy, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Accumulating Active p53 in the Nucleus by Inhibition of Nuclear Export: A Novel Strategy to Promote the p53 Tumor Suppressor FunctionExperimental Cell Research, 1999
- Are There Low-Penetrance TP53 Alleles? Evidence from Childhood Adrenocortical TumorsAmerican Journal of Human Genetics, 1999
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- The p53-deficient mouse: a model for basic and applied cancer studiesSeminars in Cancer Biology, 1996